Clinical trial
Surgery Outcome Treated by Neo-adjuvant Chemotherapy FOLFOXIRI Regimen in Colorectal Cancer With Liver-limited Synchronous Metastases
NCT05362825 is registered in ClinicalTrials.gov with Cho Ray Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surgery Outcome Treated by Neo-adjuvant Chemotherapy FOLFOXIRI Regimen in Colorectal Cancer With Liver-limited Synchronous Metastases
- Lead sponsor
- Cho Ray Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 18, 2022
- Completion date
- January 23, 2025
- Enrollment
- 89 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver metastasis colon cancer, synchronous neoplasm